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The human proto-oncogene product c-Cbl and a similar protein in Caenorhabditis elegans (Sli-1) contain a
proline-rich COOH-terminal region that binds Src homology 3 (SH3) domains of proteins such as the adapter
Grb2. Cbl-Grb2 complexes can be recruited to tyrosine-phosphorylated epidermal growth factor (EGF) recep-
tors through the SH2 domain of Grb2. Here we identify by molecular cloning a Drosophila cDNA encoding a
protein (Drosophila Cbl [D-Cbl]) that shows high sequence similarity to the N-terminal region of human c-Cbl
but lacks proline-rich sequences and fails to bind Grb2. Nonetheless, in COS-1 cells, expression of hemag-
glutinin epitope-tagged D-Cbl results in its coimmunoprecipitation with EGF receptors in response to EGF.
EGF also caused tyrosine phosphorylation of D-Cbl in such cells, but no association of phosphatidylinositol
3-kinase was detected in assays using anti-p85 antibody. A point mutation in D-Cbl (G305E) that suppresses
the negative regulation of LET-23 by the Cbl homolog Sli-1 in C. elegans prevented tyrosine phosphorylation
of D-Cbl as well as binding to the liganded EGF receptor in COS-1 cells. Colocalization of EGF receptors with
both endogenous c-Cbl or expressed D-Cbl in endosomes of EGF-treated COS-1 cells is also demonstrated by
immunofluorescence microscopy. In lysates of adult transgenic Drosophila melanogaster, GST-DCbl binds to the
tyrosine-phosphorylated 150-kDa torso-DER chimeric receptor. Expression of D-Cbl directed by the sevenless
enhancer in intact Drosophila compromises severely the development of the R7 photoreceptor neuron. These
data suggest that despite the lack of Grb2 binding sites, D-Cbl functions as a negative regulator of receptor
tyrosine kinase signaling in the Drosophila eye by a mechanism that involves its association with EGF receptors
or other tyrosine kinases.
The human proto-oncogene product c-Cbl is a 908-amino-
acid (aa) protein containing a ring finger domain and an ex-
tended proline-rich COOH terminus with multiple PXXP mo-
tifs that bind proteins having Src homology 3 (SH3) domains,
including Grb2 and Nck (4, 9, 12, 21, 23, 25, 28). Activation of
hematopoietic cells leads to rapid tyrosine phosphorylation of
c-Cbl and the recruitment of p85/phosphatidylinositol 3-kinase
(PI 3-kinase) and Crk to tyrosine phosphorylation sites on Cbl
(6, 8, 9, 12, 14, 21, 23, 25, 26, 28). In other cell types, Cbl
becomes tyrosine phosphorylated in response to a variety of
extracellular signals, including epidermal growth factor (EGF),
nerve growth factor, granulocyte-macrophage colony-stimulat-
ing factor, and transforming growth factor a (9, 11, 13, 19, 22,
23). Rapid association of c-Cbl with autophosphorylated EGF
and colony-stimulating factor 1 (CSF-1) receptors also occurs
(5, 13, 22, 32). A mechanism by which Cbl is recruited to the
EGF receptor in response to EGF appears to involve binding
of the SH2 domain of the adapter Grb2 to tyrosine-phosphor-
ylated sites on the receptor (22, 32). The oncogenic form,
v-Cbl, is a truncated 40-kDa protein lacking the ring finger and
proline-rich COOH-terminal domain (3, 17) that mediates po-
tent signals leading to cell transformation. A recent report has
shown that v-Cbl is poorly tyrosine phosphorylated upon EGF
stimulation but nonetheless is recruited to the liganded EGF
receptor (5). These and other data argue that the N-terminal
regions of c-Cbl (13) and v-Cbl (5) may also interact directly
with the EGF receptor.
The physiological functions of c-Cbl are poorly understood.
The binding of Grb2 and other proteins to c-Cbl suggests that
it may serve as a docking protein for adapter molecules to
enhance the formation of protein complexes on activated re-
ceptors at the cell membrane. Genetic data obtained with Sli-1,
a Caenorhabditis elegans protein similar to c-Cbl, indicates a
potential suppressor role in signaling by LET-23, the EGF
receptor homolog (35). Thus, expression of Sli-1 in the pres-
ence of a defective LET-23 receptor prevented vulva develop-
ment, which is dependent on the p21ras signaling pathway (24).
These data suggest the hypothesis that c-Cbl negatively mod-
ulates EGF receptor signaling and that v-Cbl may act in a
dominant inhibitory mode to block the negative influence of
c-Cbl. To clarify the role(s) of Cbl proteins in cellular signaling
processes, we searched for similar proteins expressed in Dro-
sophila melanogaster. Here we report the molecular cloning of
a gene encoding Drosophila Cbl (D-Cbl); we show that this
protein lacks the entire C-terminal proline-rich domain of
mammalian Cbl and does not bind p85 or Grb2. Despite the
lack of these sites, D-Cbl is rapidly recruited to EGF receptors
following EGF stimulation when heterologously expressed in
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mammalian cells and exerts a negative influence on the signal-
ing pathway required for R7 photoreceptor neuron develop-
ment in intact Drosophila.
MATERIALS AND METHODS
Cloning of D-Cbl. Degenerate primers were made based on two regions,
TYDEVK and YELYCEM, that share 100% amino acid sequence identity
among the human, mouse, and C. elegans homologs of Cbl. These primers were
used to amplify a 309-bp DNA fragment from Drosophila genomic DNA. This
fragment was subcloned, and sequence analysis confirmed that it contained an
open reading frame highly homologous to those encoding Cbl proteins. A Dro-
sophila eye-specific cDNA library (gift of G. M. Rubin) was screened by using the
309-bp fragment as a probe, and nine independent clones were isolated. The
longest cDNA, a 2.66-kb insert, was entirely sequenced with a model 373A DNA
sequencer (Applied Biosystems Inc.), using dye-coupled terminators.
Generation of transformants. The D-Cbl cDNA was subcloned as an EcoRI
fragment into a modified Sev-S11 vector (gift of K. Basler and E. Hafen) con-
taining two copies of the sevenless enhancer (sE) and an hsp70 promoter. The
resulting transformation construct was named sE[D-Cbl]. To generate transfor-
mant flies, Drosophila w1118 females were crossed to males containing P(D2-3) as
a source of transposase. The embryos from this cross were injected with sE[D-
Cbl], giving rise to flies carrying a D-Cbl transgene.
Drosophila binding. Flies carrying a chimeric Drosophila torso-EGF receptor
on the X chromosome controlled by an hsp70 promoter (27) were provided by
Ernst Hafen (Zurich, Switzerland) and by Jean Olivier (Toronto, Ontario, Can-
ada). Flies were heat shocked at 378C for 45 min, allowed to recover at 228C for
2.5 h, and lysed in 1% Triton X-100–10% glycerol–150 mM NaCl–20 mM Tris
(pH 7.5)–1.5 mM Mg21–1 mM EGTA containing 1 mM Na2VO4, 2.5 mg of
aprotinin per ml, and 0.1 mM phenylmethylsulfonyl fluoride. After centrifuga-
tion, clarified supernatants were incubated with 2 mg of glutathione S-transferase
(GST) or GST-DCbl for 1 h at 48C, washed twice in 0.2% Triton X-100 buffer
and once in 0.2% Triton X-100 buffer containing 0.5 M NaCl, and boiled in
sodium dodecyl sulfate (SDS) sample buffer, and proteins were resolved by
SDS-gel electrophoresis.
Antibodies and reagents. The Drosophila cDNA of 2.66 kb was amplified by
PCR with Taq polymerase to yield an N-terminal EcoRI-methionine-NcoI
0.66-kb fragment, using oligonucleotides 59-GAATTCATGGCGACGAGAGG
CAGT-39 (sense) and 59-GTGGTCTTTAGGGCCAT-39 (antisense), and a C-
terminal NcoI-BamHI 0.76-kb fragment, using oligonucleotides 59-TAATCTCC
GGCCTGGAG-39 (sense) and 59-GCGGATCCTGTGAACAAAACTATACC
-39 (antisense). Both PCR products were ligated into EcoRI-BamHI-restricted
pCMV5. Next, an epitope tag containing a methionine start codon and three
tandem copies of the hemagglutinin (HA1) epitope (34) was ligated in frame into
the EcoRI site at the N terminus of D-Cbl, and the 1.5-kb cDNA was verified by
sequencing. The G305E point mutation was generated by ligating a ClaI-BstUI
211-bp fragment and a BstUI-PstI double-stranded oligonucleotide containing
the desired mutation into pCMV5-HA D-Cbl that was restricted with ClaI and
PstI to remove the ClaI-PstI fragment. The resulting plasmid DNA was se-
quenced to confirm the mutation. A full-length D-Cbl–GST fusion protein was
generated by amplification of D-Cbl cDNA with Vent polymerase (New England
Biolabs) and ligation of the product in frame into the BamHI-EcoRI site of
pGEX2T. Fusion proteins were affinity purified on glutathione-agarose beads
(Sigma) according to standard procedures. An N-terminal human Cbl-GST fu-
sion protein, consisting of aa 26 to 283, was prepared by PCR amplification of the
human Cbl cDNA with primers 59-GATTGGGATCCTGAAGGACGC-39
(sense) and 59-GAATTTCTGGATCCGAGCTTTC-39 (antisense). The GST–
N-Cbl cDNA was cloned into pGEX2T and sequenced to ensure fidelity of
amplification, and the expressed fusion protein was injected into rabbits. The
polyclonal antibody (R4575) quantitatively precipitates Cbl from lysates of COS
cells. Polyclonal Cbl antibody for Western blots was purchased from Santa Cruz,
Inc., and EGF receptor antibody was a gift from Roger Davis, Howard Hughes
Medical Institute, University of Massachusetts Medical Center. An anti-HA
antibody (R4289) was raised in rabbits against a peptide corresponding to the
HA epitope and purified by binding to protein A-Sepharose. An anti-HA mono-
clonal antibody (MAb) (12CA5) used to blot was purchased from Berkeley
Antibody Co. Polyclonal anti-p85 antibody was purchased from Upstate Bio-
technology, Inc., and anti-Grb2 MAb was purchased from Transduction Labo-
ratories. A polyclonal Grb2 antibody was produced as described previously (21).
A phosphopeptide corresponding to the likely p85 binding site on Cbl (SCT
pYEAMYNIQSQA) was synthesized in the Peptide Synthesis Facility at the
University of Massachusetts Medical Center. The peptide was coupled to Affi-
Gel 10 as instructed by the manufacturer (Bio-Rad).
Cell culture and activation. COS-1 cells were grown in 10-cm-diameter plates
in Dulbecco’s modified Eagle’s medium containing 8% fetal calf serum. Cells
were transfected with 1 mg of cDNA in Lipofectamine (GIBCO) according to the
manufacturer’s protocol. After 2 days, subconfluent cells were serum starved for
4 h and activated at 378C with 300 ng of EGF (Preprotec) per ml for the indicated
times. Reactions were stopped with cold phosphate-buffered saline (PBS) con-
taining 0.5 mM Na2VO4, 5 mM EDTA, and 10 mM NaF and lysed in a mixture
containing 1% Nonidet P-40 (NP-40), 10 mM Tris (pH 7.5), 1 mM EDTA, 150
mM NaCl, 1 mM Na2VO4, 0.1 mM phenylmethylsulfonyl fluoride, and 2.5 mg of
aprotinin per ml.
Immunofluorescence microscopy. COS-1 cells were seeded on coverslips and
transfected with Lipofectamine and after 2 days were serum starved. EGF (300
ng/ml) was added for 20 min; the cells were washed in cold PBS and fixed in cold
4% formaldehyde. Cells were permeabilized and blocked in PBS containing 1%
fetal bovine serum and 0.5% Triton-X 100 for 20 min. Primary antibodies were
sheep anti-EGF receptor, rabbit anti-Cbl, and rabbit anti-HA; secondary anti-
bodies were donkey anti-rabbit–fluorescein isothiocyanate (FITC; Pierce) or
donkey anti-sheep–rhodamine (Cortex Biochemicals). Cells were mounted in
90% glycerol–PBS–2.5% 1,4-diazabicyclo-(2,2,2)-octane, and images were taken
with a digital imaging microscope (Nikon Diaphot 200) fitted with a Nikon
Apo60/1.4 immersion lens.
Immunoprecipitation and blotting. Antibodies were mixed with clarified ly-
sates containing 0.5 mg of protein and incubated at 48C overnight. Protein
A-Sepharose was added for 15 min with constant shaking; beads were subse-
quently washed several times in 0.2% NP-40 buffer and once in 0.2% NP-40
buffer containing 0.5 M NaCl. Proteins were resolved by SDS-polyacrylamide gel
electrophoresis, transferred to nitrocellulose, and blotted. Detection was by
chemiluminescence (Boehringer Mannheim).
Nucleotide sequence accession number. The nucleotide sequence of Drosoph-
ila Cbl has been submitted to GenBank and given accession number U87925.
RESULTS
Isolation of a Drosophila cDNA related to the proto-onco-
gene c-cbl. A D-cbl DNA fragment was PCR amplified from
Drosophila genomic DNA by using a set of degenerate primers.
Screening of a Drosophila eye disc cDNA library with this
fragment led to the isolation of a 2.66-kb cDNA containing 313
nucleotides of 59 noncoding region, a 1,344-nucleotide open
reading frame preceding an in-frame TAG stop codon, and
1,317 nucleotides of 39 noncoding region. A comparison of the
derived amino acid sequences of human-Cbl, D-Cbl, and C.
elegans Cbl (Sli-1) (Fig. 1A) shows no homology over the first
40 aa or beyond residue 426 of D-Cbl. However, within the
conserved region of approximately 380 aa, the three species
show 63% similarity between aa 46 and 205 and 93% similarity
between aa 205 and 330. Within the N-terminal conserved
region, several tyrosine residues found in human Cbl are not
present in D-Cbl, including the human Y141EEN sequence
(F129EDN in D-Cbl), which is a potential Src kinase SH2
binding motif. A high degree of similarity is also observed
between aa 354 and 425. This region includes a ring finger
domain and a sequence of 17 aa (called 70Z/3) which, when
deleted, renders c-Cbl transforming (1, 3, 4). Interestingly,
D-Cbl is only 93 residues longer than v-Cbl (Fig. 1B), but these
amino acids include the important 70Z/3 sequence and ring
finger regions. Finally, unlike the protein found in C. elegans or
mammals, D-Cbl contains no proline-rich motifs.
D-Cbl negatively regulates R7 development. In the develop-
ing Drosophila eye, the differentiation of photoreceptor neu-
rons (R cells) depends on signaling through the Sevenless and
EGF receptor tyrosine kinases (reviewed in reference 36). The
developing eye constitutes a genetic system where the in vivo
function of Drosophila Cbl could be studied. Mutations in the
D-cbl locus have not yet been identified, and the region en-
coding this locus is not covered by deficiencies or transposable
elements. We therefore generated transformant flies carrying
the D-Cbl cDNA under the transcriptional control of sE, which
will cause the expression of the D-Cbl cDNA in all cells that
express Sevenless, including the R7 photoreceptor precursor
(2). To assess the role of D-Cbl in R7 development, we tested
these transgenic flies in a sensitized genetic assay (reviewed in
reference 7). In this assay, signaling through Sevenless is com-
promised by using a disabled Sevenless kinase, sevE4. This
defect is partially rescued by combining sevE4 with one copy of
SosJC2, an allele of the son of sevenless gene encoding an over-
active protein. In the resulting sevE4/Y; SosJC2/1 fly, the re-
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ceptor tyrosine kinase signal is weakened so that an R7 cell
develops in only 17% of the facets (ommatidia) in the eye (Fig.
2).
The above-described genetic background is extremely sensi-
tive to the dosage of genes participating in receptor tyrosine
kinase signaling, and the fraction of ommatidia developing R7
cells is a readout for the strength of the transduced signal. We
have previously shown that removing a single copy of a positive
regulator such as Ras or Sos abolishes the development of R7
cells in this genetic background, while removing one copy of a
negative regulator, such as GAP1, will increase this number
significantly (29). Removing a copy of the EGF receptor in this
background also completely abrogates R7 differentiation (Fig.
2). This finding suggests that the R7 developmental readout is
due to the combination of Sev and EGF receptor tyrosine
kinase signals. This result is consistent with the recent obser-
vations of Freeman (10) showing that both of these receptors
are essential for R7 development. We introduced a copy of the
D-Cbl transgene in the sensitized background to generate a fly
of the genotype sevE4/Y; SosJC2/1; sE[D-Cbl]. In the three
independently generated transgenic lines shown, the develop-
ment of R7 cells was essentially eliminated when the level of
FIG. 1. (A) Comparison of the amino acid sequences of D-Cbl with those of human Cbl (H-Cbl) and C. elegans Cbl (CESli-1). The most conserved region of the
three proteins, from residues 205 to 330 of dCbl, is overlined. The 70Z/3 17-aa sequence is underlined, and the ring finger domain is boxed. (B) Schematic representation
of human c-Cbl, D-Cbl, C. elegans Cbl (CeCbl), and v-Cbl.
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D-Cbl was raised in the R7 precursors (Fig. 2). No change in
phenotype was observed when D-Cbl was added to flies with a
wild-type genetic background (data not shown). This result
strongly argues that in the Drosophila eye, D-Cbl acts as a
negative regulator of one or more receptor tyrosine kinase
pathways that are essential for photoreceptor differentiation.
D-Cbl does not bind p85 or Grb2. Since D-Cbl does not
contain any of the proline-rich domain found in the C. elegans
Sli-1 homolog or in mammalian Cbl (Fig. 1) and has only one
(Y370CEM) of two possible p85 binding sites, we tested
whether Grb2 or p85 was bound to D-Cbl. This was accom-
plished by heterologously expressing D-Cbl or human c-Cbl in
COS-1 monkey kidney cells and activating with EGF. COS-1
cells were transiently transfected with HA epitope-tagged D-
Cbl cDNA or human c-Cbl cDNA 48 h prior to lysis and
immunoprecipitation with anti-c-Cbl or anti-HA antibody. Im-
munoblots of anti-HA precipitates with anti-p85 showed no
detectable p85 associated with D-Cbl (Fig. 3, lanes 5 and 6),
consistent with the lack of the Y731EAM motif in D-Cbl. In
COS cells transfected with c-Cbl cDNA, an EGF-dependent
binding of p85 to Cbl is observed, as expected (Fig. 3, lanes 3
and 4), and immobilized phosphopeptide containing the c-Cbl
SH2 recognition motif (Y731EAM) for p85 binds a similar
amount of p85 (Fig. 3, lane 7). These data indicate that the p85
concentration in these lysates is not rate limiting for binding to
D-Cbl and that the Y731EAM motif is phosphorylated by EGF
and binds p85 in these cells. The Grb2 immunoblot (Fig. 3,
middle panel) of the anti-HA and anti-Cbl immunoprecipitates
shows that Grb2 is bound to Cbl in c-Cbl-transfected cells (Fig.
3, lanes 3 and 4) but is not associated with D-Cbl (Fig. 3, lanes
5 and 6). Interestingly, activation of COS-1 cells with EGF
causes more Grb2 to be complexed with Cbl (Fig. 3, lane 4),
consistent with an increased Grb2/Cbl stoichiometry observed
in activated Jurkat T cells (21), as well as EGF-activated 293
kidney (22) and human mammary epithelial cells (12).
Recruitment of D-Cbl to the EGF receptor. c-Cbl is recruited
to the EGF receptor in mammalian cells following EGF stim-
ulation (5, 13, 22, 32) and appears to negatively regulate EGF
receptor and/or Sevenless signaling inDrosophila (Fig. 2). In C.
elegans, the 582-residue Sli-1 homolog of c-Cbl appears to be a
negative regulator of the EGF receptor homolog, LET-23 (35).
We therefore examined whether HA epitope-tagged D-Cbl
expressed in COS-1 cells becomes associated with the EGF
receptor. Control experiments were first conducted with c-Cbl
in the COS-1 cell system to ensure that EGF stimulation of
these cells causes formation of EGF receptor–c-Cbl com-
plexes. Figure 4 shows that expression of c-Cbl (lane 3 and 4 or
7 and 8) is indeed accompanied by an EGF-dependent increase
in a tyrosine phosphorylated p170 bound to c-Cbl immunopre-
cipitates (top [compare lanes 6 and 8]) and that p170 immu-
noreacts with EGF receptor antibody (bottom, lane 8). Com-
plexes of EGF receptor and endogenous c-Cbl in
nontransfected cells are also readily observed in these experi-
ments (top, lanes 5 and 6). Unlike the transient phosphoryla-
tion of c-Cbl in response to T-lymphocyte activation (9, 21),
tyrosine phosphorylation of the EGF receptor and Cbl in
COS-1 cells is more stable, exhibiting a half-life of 2 h (not
shown).
Transfection of COS-1 cells with the HA epitope-tagged
D-Cbl cDNA (Fig. 5) revealed a p60 polypeptide correspond-
FIG. 2. D-Cbl is a negative regulator of R7 development. The number of
developing R7 cells in a sevE4/Y; SosJC2/1 genetic background is sensitive to a
single-copy loss-of-function mutation in the EGF receptor (egfr) and to the
sE[D-Cbl] transgene. The eyes were scored by the pseudopupil technique, and
for each genotype at least 2,000 ommatidia were counted.
FIG. 3. Grb2 and p85 do not associate with D-Cbl. COS-1 cells were trans-
fected with c-Cbl (lanes 3 and 4) or HA-DCbl cDNA (lanes 5 and 6) and
activated with EGF for 5 min. Lysates containing 500 mg of protein were immu-
noprecipitated (IP) with anti-Cbl (a-Cbl; lanes 1 to 4) or anti-HA (a-HA; lanes
5 and 6). A p85 phosphopeptide coupled to Affi-Gel (lane 7, top panel) or
anti-Grb2 coupled to protein A-Sepharose (lane 7, middle panel) was added to
lysates from EGF-activated cells. After electrophoresis, nitrocellulose filters
were blotted with the indicated antibody.
FIG. 4. Human c-Cbl is recruited to the EGF receptor upon EGF stimula-
tion of transiently transfected COS-1 cells. Cells containing endogenous Cbl
(lanes 1, 2, 5, and 6) or transfected with c-Cbl (lanes 3, 4, 7, and 8) were activated
with EGF (310 ng/ml) for 20 min. Lysates were prepared, and 500 mg of protein
was immunoprecipitated with anti-Cbl (a-Cbl) and blotted with antiphosphoty-
rosine (a-PY; top), anti-Cbl (middle), or anti-EGF receptor (a-EGFR; bottom).
Lanes 1 to 4, 10 mg of total cell lysate. Sizes are indicated in kilodaltons.
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ing to the expected migration of D-Cbl in lysates and in an-
ti-HA immunoprecipitates of transfected cells that was immu-
noreactive with anti-HA MAb. This polypeptide band was not
found in anti-HA immunoprecipitates of nontransfected cells
(Fig. 5, lane 3). In nonstimulated cells, D-Cbl was tyrosine
phosphorylated (lanes 1 and 4), and activation with EGF led to
increased phosphorylation (lanes 2 and 5), as well as the ap-
pearance of p170 in anti-HA immunoprecipitates (top, lane 5).
Blotting anti-HA immunoprecipitates of COS-1 cells trans-
fected with D-Cbl cDNA with anti-EGF receptor (bottom,
lane 5) showed that D-Cbl is recruited to the 170-kDa EGF
receptor in an activation-dependent manner. These results
were confirmed by identifying D-Cbl in immunoprecipitates of
the EGF receptor (Fig. 6). When EGF receptors were immu-
noprecipitated from D-Cbl-transfected cells and immunoblot-
ted with anti-HA antibody, a small amount of D-Cbl was
present. EGF addition to the COS-1 cells increased this asso-
ciation of D-Cbl with EGF receptors several fold (lanes 5 and
6).
A Gly315-to-Glu point mutation in the C. elegans homolog of
Cbl, Sli-1, suppresses the ability of this protein to act as a
negative regulator of LET-23 signaling (35). We therefore
tested whether the association of D-Cbl and the EGF receptor
was also prevented by the analogous mutation in D-Cbl. In Fig.
7, COS-1 cells were transfected with D-Cbl or the correspond-
ing G305E D-Cbl point mutation, and after stimulation with
EGF, detergent-soluble lysates were immunoprecipitated with
anti-HA. The anti-HA blot shows that although the wild-type
and mutant proteins were expressed to the same extent (Fig. 7,
bottom, lanes 2 and 3), only D-Cbl was bound to the EGF
receptor (top, lane 3). Importantly, the G305E mutation of
D-Cbl totally prevented tyrosine phosphorylation of the ex-
pressed protein by EGF (middle, lanes 2 and 3). We conclude
that the loss-of-function mutation in C. elegans acts by prevent-
ing the association of Cbl with the EGF receptor.
The association of transiently expressed D-Cbl with liganded
EGF receptors in COS-1 cells was confirmed in Drosophila by
in vitro binding of a D-Cbl fusion protein to extracts of flies
expressing a chimeric torso-DER receptor. The chimeric re-
ceptor consists of the extracellular domain of a mutant torso
receptor fused to the cytoplasmic domain of DER under the
control of the hsp70 heat shock promoter (27). In Fig. 8, heat
shock of adult transgenic Drosophila for 45 min at 378C, fol-
lowed by a recovery at 228C for 3 h, causes a pronounced
tyrosine phosphorylation of many proteins (lanes 1 and 2).
FIG. 5. EGF stimulates recruitment of D-Cbl to the EGF receptor in tran-
siently transfected COS-1 cells. Cells were transfected with HA-DCbl and 48 h
later serum starved for 2 h. Cells were activated with EGF (310 ng/ml), and
detergent-soluble lysates were immunoprecipitated (IP) with anti-HA (a-HA).
Proteins bound to nitrocellulose filters were blotted with antiphosphotyrosine
(a-PY; top), anti-HA (middle), or anti-EGF receptor (a-EGFR; bottom). Lanes
1 and 2, 10 mg of total cell lysates; lanes 3 to 5, anti-HA immunoprecipitates.
Lane 3, lysates of nontransfected cells immunoprecipitated with anti-HA.
FIG. 6. Immunoprecipitates of COS-1 cell EGF receptors contain D-Cbl.
Cells were transfected with HA-DCbl as noted and activated for 20 min with
EGF, and 0.5 mg of detergent-soluble lysates was immunoprecipitated with
anti-HA (a-HA; lanes 1 to 3) or anti-EGF receptor (a-EGFR; lanes 4 to 6).
Lanes 7 to 9, 10 mg of total cell lysates. Sizes are indicated in kilodaltons.
FIG. 7. A G305E point mutation in D-Cbl prevents binding to the liganded
EGF receptor (EGFR) in COS-1 cells. Cells were transfected with HA-DCbl
(lane 3) or HA-G305E-DCbl (lane 2) and activated with EGF, and lysates were
immunoprecipitated with anti-HA. Proteins bound to nitrocellulose filters were
blotted to anti-HA (bottom) or antiphosphotyrosine (anti-PY).
FIG. 8. D-Cbl binds in vitro to the Drosophila EGF receptor. Adult Drosoph-
ila flies transfected with a torso-DER chimeric receptor were heat shocked for 45
min. After recovery, lysates from control (2) and heat-shocked (1) flies were
prepared in a 1% Triton X-100 buffer, and 0.5 (lanes 5 and 6) or 1.0 (lanes 7 and
8) mg of protein was bound to 2 mg of GST-DCbl. Washed complexes bound to
glutathione-agarose were electrophoresed, transferred to nitrocellulose, and
blotted with antiphosphotyrosine. In lanes 3 and 4, 2 mg of GST protein was
bound to 1 mg of cell lysate from heat-shocked flies. Lanes 1 and 2, 20 mg of total
cell lysates (lys). Sizes are indicated in kilodaltons.
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Addition of GST–D-Cbl fusion protein to 0.5 mg (lanes 5 and
6) or 1.0 mg (lanes 7 and 8) of cell lysate resulted in the binding
of a 150-kDa protein in extracts of flies subjected to heat shock
but not to control flies. No tyrosine-phosphorylated bands ap-
peared in lysates reacted with a GST fusion protein (lanes 3
and 4). A GST-Grb2 fusion protein also binds strongly to a
150-kDa protein in extracts of activated flies (data not shown),
confirming that p150 is DER.
Colocalization of D-Cbl and human c-Cbl with the EGF
receptor. The biochemical evidence indicating a ligand-depen-
dent association of human c-Cbl and D-Cbl with the EGF
receptor (Fig. 4 to 6) was further evaluated by examining the
subcellular localization of these proteins after EGF stimula-
tion. For this purpose, COS-1 cells were grown on coverslips
and incubated with or without EGF for 20 min before washing
and fixing in cold formaldehyde. COS-1 cells transfected with
D-Cbl cDNA were double stained with anti-HA antibody (vi-
sualized with FITC-labeled secondary antibody) and anti-EGF
receptor antibody (visualized with rhodamine-labeled second-
ary antibody). Endogenous c-Cbl in nontransfected cells was
detected with anti-c-Cbl antibody and visualized with FITC-
labeled secondary antibody. Prior to the addition of EGF,
endogenous EGF receptor and c-Cbl appear diffuse (Fig. 9C
and D), whereas 20 min after EGF addition, the EGF receptor
becomes internalized, as evidenced by the punctate rhodamine
staining (Fig. 9F). Visualization of the same cell with anti-Cbl
(Fig. 9E) shows that a portion of endogenous c-Cbl becomes
colocalized with the internalized EGF receptor. COS cells that
overexpress Cbl show the same pattern, although the greater
intensity of Cbl staining throughout the cell obscures the punc-
tate signal to some degree (data not shown).
Immunofluorescence microscopy staining of D-Cbl-trans-
fected COS cells reveals a similar pattern of colocalization of
D-Cbl with the EGF receptor in EGF-activated cells. Thus, in
serum-starved cells, D-Cbl appears to be diffuse (Fig. 9A),
whereas 20 min after addition of EGF, a fraction of cellular
D-Cbl becomes concentrated in EGF receptor-enriched vesi-
cles (Fig. 9G and H). We conclude that EGF causes D-Cbl and
c-Cbl to be translocated into internalized vesicles containing
the EGF receptor, consistent with the physical association of
the Cbl proteins with EGF receptors (Fig. 4 and 5).
DISCUSSION
Signaling events initiated by receptor tyrosine kinases are
crucial for establishing the identity of photoreceptor neurons
in the developing Drosophila eye. We have molecularly char-
acterized D-Cbl, the Drosophila homolog of the c-Cbl onco-
gene product. Genetic experiments have demonstrated that in
flies expressing elevated levels of D-Cbl in the R7 precursor,
the development of this cell as a photoreceptor neuron is
compromised (Fig. 2). This finding strongly suggests that D-
Cbl is normally involved in the negative regulation of receptor
tyrosine kinase-mediated signals. These results, as well as those
of Freeman (10), suggest that in addition to Sevenless signal-
ing, EGF receptor activity is also required for R7 cell fate
determination. Therefore, the negative regulatory function of
D-Cbl on R7 cell differentiation reflects its participation either
in EGF receptor signaling or in Sevenless signaling, or possibly
in both. This genetic interaction between D-Cbl and the re-
ceptor tyrosine kinase pathway is consistent with our biochem-
ical analysis showing that D-Cbl binds to the EGF receptor
(Fig. 4 to 6).
A major finding in this work is that D-Cbl is devoid of a
COOH-terminal domain containing proline-rich Grb2 binding
motifs. Much of the previous work on the proto-oncogene
c-Cbl protein has focused on identification of signaling pro-
teins that associate with its proline-rich motifs through SH3
binding or its tyrosine phosphate sites through SH2 binding.
These associated proteins include Src family tyrosine kinases,
Grb2, Nck, Crk-G3G complexes, and PI3 kinases (8, 9, 14, 21,
23, 25, 26, 28, 30). Interestingly, the motifs thought to bind all
of these associated proteins are believed to reside in the pro-
line-rich COOH-terminal region of c-Cbl containing residues
480 to 850. The recently identified C. elegans Cbl homolog,
Sli-1, lacks much of this COOH-terminal domain but does
contain several proline-rich motifs between aa 470 and 570 that
can serve as binding sites for the adapter Grb2. We confirmed
that D-Cbl does not bind Grb2 or PI3 kinases upon its tran-
sient expression in COS-1 cells (Fig. 3). Thus, our data indicate
that D-Cbl can function in Drosophila without the Grb2 ho-
molog Drk or the many other signaling proteins that bind this
region in c-Cbl.
The binding of c-Cbl to Grb2 through the adapter’s N-
terminal SH3 domain appears to mediate the recruitment of
c-Cbl to activated EGF receptors through binding of the Grb2
SH2 domain to receptor tyrosine phosphorylation sites. How-
ever, D-Cbl, which has high sequence similarity to the N-
terminal domain of c-Cbl, does retain the ability to be re-
cruited to EGF receptors upon EGF activation of COS-1 cells
(Fig. 4 to 6). We have also demonstrated that the tyrosine-
phosphorylated Drosophila EGF receptor DER binds to a
GST–D-Cbl fusion protein in detergent-soluble lysates of adult
flies. Thus, the N-terminal region of Cbl proteins appears to
provide a second means of EGF receptor association, as sug-
gested by studies with v-Cbl (5) and the N-terminal region of
c-Cbl (13). That this is a direct binding is indicated by far-
Western blotting of EGF receptors with a GST fusion protein
containing the N-terminal region of c-Cbl (13). Taken to-
gether, the data now available are consistent with a key role of
this EGF receptor-binding N-terminal domain in the function-
ing of c-Cbl.
A physiologically relevant functional domain within the N-
terminal region of c-Cbl proteins is supported by the approx-
imate 68% amino acid sequence identity of human Cbl to
D-Cbl between residues 40 and 426 of D-Cbl. Although the
exact residues in Cbl that interact with the liganded EGF
receptor have not been identified, we have found that a GST
fusion protein encompassing the N-terminal 160 aa of c-Cbl
does not associate (not shown). Based on the G305E mutation
in D-Cbl that ablates receptor association (Fig. 7), it seems
plausible that the most highly conserved region of Cbl (aa 205
to 330) may be sufficient for EGF receptor binding. It is pos-
sible that this core region of Cbl binds directly to other tyrosine
kinases as well. For example, the N terminus of c-Cbl (aa 1 to
357) binds in vitro to ZAP-70 in activated T cells, and the
loss-of-function point mutant G306E largely prevents this in-
teraction (20). In T cells activated through the CD3 receptor,
c-Cbl binds directly to the Src kinase Fyn in an activation-
dependent manner (33), although the region of Cbl responsi-
ble for this interaction was not identified. A tyrosine kinase
receptor with similarity to the EGF receptor is the hematopoi-
etic cell CSF-1 receptor, and in the macrophage cell line
P388D1, Cbl is recruited to the activated CSF-1 receptor (32).
However, it is not established whether this binding is mediated
through Grb2 or through the Cbl N-terminal domain, or both.
It will be important in future studies to determine what struc-
tural motif or motifs in these tyrosine kinases binds D-Cbl and
whether such motifs appear in other proteins.
It is striking that the association of EGF receptors with
D-Cbl and c-Cbl observed by biochemical techniques can be
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FIG. 9. Colocalization of D-Cbl and c-Cbl with internalized EGF receptors following activation with EGF. Cells were serum starved for 1 h and stimulated for 20
min. with EGF. After fixing and permeabilizing, cells were stained with sheep anti-EGF receptor (anti-EGFR) and donkey anti-sheep–rhodamine. Human Cbl was
visualized with rabbit anti-Cbl plus donkey anti-rabbit–FITC; D-Cbl was visualized with rabbit anti-HA plus donkey anti-rabbit–FITC. (C to F) Nontransfected COS-1
cells; (A, B, G, and H) HA-DCbl-transfected cells.
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visualized by immunofluorescence microscopy of intact COS-1
cells (Fig. 9). Colocalization of Cbl proteins and EGF recep-
tors can be observed as early as a few minutes after addition of
EGF to these cells (not shown), and by 20 min of incubation,
an intense punctate pattern of Cbl and the EGF receptor
proteins is evident. It is noteworthy that these images can be
visualized with endogenous EGF receptors in the COS-1 cells.
Our data are consistent with the hypothesis that Cbl-EGF
receptor complexes are internalized into endosomes through
the coated pit pathway, as previously described for EGF re-
ceptors (31). Previously, Tanaka et al. (32) demonstrated by
immunofluorescence that Cbl is translocated to a perinuclear
region after Fcg receptor cross-linking or EGF stimulation.
The continued association of D-Cbl and c-Cbl proteins with
EGF receptors traffiking within intracellular membranes cor-
relates with the known retention of phosphorylated tyrosine
residues and active tyrosine kinase activity in the intracellular
EGF receptors (15, 16, 31). It seems likely from these obser-
vations that modulation of EGF function by Cbl proteins in-
volves the transient association with both cell surface and in-
tracellular EGF receptors. In this context, it is intriguing that
mutations in the sli-1 gene, encoding the C. elegans homolog of
Cbl, have been shown to interact genetically with unc-101 in
the regulation of the EGF receptor pathway leading to vulval
differentiation (18). unc-101 encodes a clathrin-associated pro-
tein homologous to mouse AP47, which constitutes one of the
main components of coated pits and vesicles. Although sli-1
mutations alone are silent, in combination with unc-101 muta-
tions, they cause excessive vulval differentiation. These gene
products, thus, appear to cooperate synergistically in the neg-
ative control of EGF receptor signaling. Part of the mechanism
whereby Cbl proteins exert an attenuation on receptor tyrosine
kinase signaling might involve the downregulation of receptor
activity by directing the intracellular degradation of the recep-
tor-Cbl complexes.
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